Lombard Odier Asset Management (Switzerland)’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Lombard Odier Asset Management (Switzerland)’s Portfolio DRNA Stock Details DRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-701,305	Closed	-$14.1M	–	413
2021 Q3	$14.1M	Buy	701,305 +65,294	+10%	+$1.8M	0.88%	48
2021 Q2	$23.7M	Buy	636,011 +109,953	+21%	+$3.37M	1.2%	31
2021 Q1	$13.5M	Buy	+526,058	New	+$13.4M	0.89%	44

Other funds holding DRNA

CAM

Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return

Lombard Odier Asset Management (Switzerland)'s DRNA Position: Q4 2021 in Review

Lombard Odier Asset Management (Switzerland) sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q4 2021, closing a stake of 701,305 shares — an estimated $14.1M sold.

Lombard Odier Asset Management (Switzerland) first reported a position in DRNA in Q1 2021 and held it in 3 quarters. The position peaked at $23.7M in Q2 2021. 1 fund tracked by Wall St. Rank holds DRNA as of Q4 2021.

Lombard Odier Asset Management (Switzerland) reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
Lombard Odier Asset Management (Switzerland) sold 701,305 Dicerna Pharmaceuticals, Inc. shares in Q4 2021, an estimated $14.1M.
Lombard Odier Asset Management (Switzerland) first reported a position in Dicerna Pharmaceuticals, Inc. in Q1 2021 and held it in 3 quarters.
Lombard Odier Asset Management (Switzerland)'s Dicerna Pharmaceuticals, Inc. position peaked at $23.7M in Q2 2021.
1 fund tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q4 2021.

Based on Lombard Odier Asset Management (Switzerland)'s 13F filing for Q4 2021, filed 14 Feb 2022.